Wednesday, October 13, 2021 | 1:00 PM - 2:00 PM EST

Discussion will focus on biotech investment trends – what has worked and is still working, availability of capital, the types of companies succeeding and lessons learned from those experiencing difficulties getting traction – along with an outlook for the year ahead. Our guest speakers from SVB Leerink represent the Investment Banking and Equity Capital Markets arenas and will provide invaluable insight on their outlook for biotech IPOs, crossovers, follow-ons and SPACs, as well as the deal environment for 2022.

 

AGENDA

Opening Remarks | Moderation 

  • Robert Uhl, Managing Director, Westwicke 
  • Patti Bank, Managing Director, Westwicke 

Panelists

  • Gabriel Cavazos, Senior Managing Director, Biotechnology, SVB Leerink
  • Jack Bannister, Managing Director, Equity Capital Markets, SVB Leerink

SPEAKERS  - Click on name for bio 

Robert Uhl
Robert Uhl
Westwicke
Managing Director

Patti Bank
Patti Bank
Westwicke
Managing Director

Gabriel Cavazos
Gabriel Cavazos
SVB Leerink
Senior Managing Director, Biotechnology

Jack Bannister
Jack Bannister
SVB Leerink
Managing Director, Equity Capital Markets

RESOURCES 

SVB Leerink | Slide Deck

Westwicke | Slide Deck

Westwicke | About Us

Westwicke | Services